{"transactions":[{"id":1759886,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":1,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":2,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":4,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-10-16T20:51:41.000Z","date":"2023-10-13","kind":"sale","planned":false,"acquired":false,"shares":1076841,"price":0.1038,"value":111776.0958,"ownership":{"direct":true},"balance_after":0,"source":{"system":"sec-edgar","filing":"0001760460-23-000008","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000008/primary_doc.xml","form_type":"4"}},{"id":1864010,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":4,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-06-07T21:21:26.000Z","date":"2023-06-07","kind":"sale","planned":false,"acquired":false,"shares":134421,"price":0.83,"value":111569.43,"ownership":{"direct":true},"balance_after":1076841,"source":{"system":"sec-edgar","filing":"0001760460-23-000006","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000006/primary_doc.xml","form_type":"4"}},{"id":1884752,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":3,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2023-05-19T20:55:49.000Z","date":"2023-05-18","kind":"sale","planned":false,"acquired":false,"shares":560000,"price":9.46,"value":5297600.0,"ownership":{"direct":true},"balance_after":1211262,"source":{"system":"sec-edgar","filing":"0001760460-23-000003","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046023000003/primary_doc.xml","form_type":"4"}},{"id":2677798,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-06-08T12:37:09.000Z","date":"2021-06-07","kind":"grant","acquired":true,"shares":8189,"price":4,"value":32756.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"1. These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1771262,"source":{"system":"sec-edgar","filing":"0001760460-21-000004","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000004/primary_doc.xml","form_type":"4"}},{"id":2739700,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":304286,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":685236,"derivative":{"exercise_price":18.63,"exercise_date":"2018-03-29","expiration_date":"2022-09-29","underlying":"Common Stock","underlying_shares":304286},"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2739699,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Warrants (Right to buy)","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":380950,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":380950,"derivative":{"exercise_price":12,"exercise_date":"2016-11-29","expiration_date":"2023-11-29","underlying":"Common Stock","underlying_shares":380950},"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":2739698,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-04-26T12:39:28.000Z","date":"2021-04-26","kind":"grant","acquired":true,"shares":609231,"price":4,"value":2436924.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1763077,"source":{"system":"sec-edgar","filing":"0001760460-21-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046021000002/primary_doc.xml","form_type":"4"}},{"id":3075601,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-07-27T16:42:27.000Z","date":"2020-07-23","kind":"grant","acquired":true,"shares":7383,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The grant consists of RSUs that fully vest one year from the date of grant, or July 23, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"After taking into account the 1-for-15 reverse stock split effective March 24, 2020."}],"balance_after":9958,"source":{"system":"sec-edgar","filing":"0001209191-20-043737","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919120043737/doc4.xml","form_type":"4"}},{"id":3137479,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":1,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-22T07:25:14.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":1153846,"price":13,"value":14999998.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"These securities are held directly by Puissance Life Science Opportunities Fund VI and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Life Science Opportunities Fund VI; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Life Science Opportunities Fund VI; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Persons each disclaim beneficial ownership of the reported securities except to the extent of its pecuniary interest therein. This report shall not be deemed an admission that any Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":1153846,"source":{"system":"sec-edgar","filing":"0001760460-20-000002","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000176046020000002/primary_doc.xml","form_type":"4"}},{"id":3173104,"issuer":{"id":108982,"kind":"organization","name":"Bellerophon Therapeutics, Inc.","symbol":"BLPH"},"owners":[{"id":149751,"kind":"organization","name":"Puissance Cross-Border Opportunities III LLC","position":1,"cik":"0001718111","reported_name":"Puissance Cross-Border Opportunities III LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":2,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":4,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":5,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-20T10:47:45.000Z","date":"2020-04-17","kind":"other","acquired":false,"shares":553250,"ownership":{"direct":false,"nature":"By Puissance Cross-Border Opportunities III LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Puissance Cross-Border Opportunities III LLC made an in-kind distribution of an aggregate 553,250 shares of the Issuer's common stock to its limited partners in connection with the redemption of partnership interests."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Puissance Cross-Border Opportunities III LLC made an in-kind distribution of an aggregate 553,250 shares of the Issuer's common stock to its limited partners in connection with the redemption of partnership interests."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Puissance Cross-Border Opportunities III LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities III LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities III LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001718111-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1718111/000171811120000001/primary_doc.xml","form_type":"4"}},{"id":3227817,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-03-04T20:42:33.000Z","date":"2020-03-02","kind":"other","acquired":false,"shares":8918898,"ownership":{"direct":false,"nature":"By Puissance Cross-Border Opportunities II LLC"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 8,918,898 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Puissance Cross-Border Opportunities II LLC made an in-kind distribution of an aggregate 8,918,898 shares of the Issuer's common stock to one of its limited partners in connection with the redemption of partnership interests."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"These securities are held directly by Puissance Cross-Border Opportunities II LLC and may be deemed to be beneficially owned by Puissance Capital Management LP, the investment manager of Puissance Cross Border Opportunities II LLC; Puissance Capital Management (GP) LLC, the general partner of Puissance Capital Management LP; Puissance Capital Fund (GP) LLC, the general partner of Puissance Cross Border Opportunities II LLC; and Theodore T. Wang, the managing member of Puissance Capital Management (GP) LLC and Puissance Capital Fund (GP) LLC. The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of his pecuniary interest therein. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose."}],"balance_after":11616000,"source":{"system":"sec-edgar","filing":"0001717781-20-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000171778120000001/primary_doc.xml","form_type":"4"}},{"id":3306512,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-21T20:58:11.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":136496,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of July 1, 2019."}],"balance_after":136496,"derivative":{"exercise_price":0.38,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":136496},"source":{"system":"sec-edgar","filing":"0001209191-20-004378","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919120004378/doc4.xml","form_type":"4"}},{"id":3306511,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-01-21T20:58:11.000Z","date":"2020-01-16","kind":"grant","acquired":true,"shares":19445,"price":0.45,"value":8750.25,"ownership":{"direct":true},"balance_after":38624,"source":{"system":"sec-edgar","filing":"0001209191-20-004378","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919120004378/doc4.xml","form_type":"4"}},{"id":3345394,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":4,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":6,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T10:47:42.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":340134,"price":2.92,"value":993191.28,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Puissance Cross-Border Opportunities IV LLC made an in-kind distribution of 176,992 shares of common stock. Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 163,142 shares of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"Consists of: 76,048 Shares directly owned by Puissance Cross-Border Opportunities V LLC."}],"balance_after":76048,"source":{"system":"sec-edgar","filing":"0001733439-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1733439/000173343919000001/primary_doc.xml","form_type":"4"}},{"id":3345393,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":3,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":4,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":6,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-11T10:47:42.000Z","date":"2019-12-05","kind":"sale","acquired":false,"shares":43996,"price":3.05,"value":134187.8,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Puissance Cross-Border Opportunities V LLC made an in-kind distribution of 43,996 shares of common stock."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F2","text":"Consists of: 239,190 Shares directly owned by Puissance Cross-Border Opportunities V LLC; 176,992 Shares directly owned Puissance Cross-Border Opportunities IV LLC."}],"balance_after":416182,"source":{"system":"sec-edgar","filing":"0001733439-19-000001","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1733439/000173343919000001/primary_doc.xml","form_type":"4"}},{"id":3745921,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"sale","acquired":false,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745920,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T10:14:33.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000016","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000016/primary_doc.xml","form_type":"4/A","original_submission_date":"2018-12-03"}},{"id":3745919,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"sale","acquired":true,"shares":4326,"price":1.21,"value":5234.46,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4601768,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}},{"id":3745918,"issuer":{"id":91134,"kind":"organization","name":"Tracon Pharmaceuticals, Inc.","symbol":"TCON"},"owners":[{"id":153197,"kind":"organization","name":"Puissance Cross-Border Opportunities V LLC","position":1,"cik":"0001733439","reported_name":"Puissance Cross-Border Opportunities V LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":153198,"kind":"organization","name":"Puissance Cross-Border Opportunities IV LLC","position":2,"cik":"0001718140","reported_name":"Puissance Cross-Border Opportunities IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108983,"kind":"organization","name":"Puissance Life Science Opportunities Fund VI","position":3,"cik":"0001760460","reported_name":"Puissance Life Science Opportunities Fund VI","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":6,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108985,"kind":"person","name":"Wang Theodore T","position":7,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-12-03T09:39:59.000Z","date":"2018-11-29","kind":"purchase","acquired":true,"shares":4326,"price":1.13,"value":4888.38,"ownership":{"direct":false,"nature":"By funds"},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F4","text":"The purchase and sale of 4,326 shares of Common Stock were under the fund Puissance Life Science Opportunities Fund VI."}],"balance_after":4606094,"source":{"system":"sec-edgar","filing":"0001733439-18-000015","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1760460/000173343918000015/primary_doc.xml","form_type":"4"}},{"id":3850900,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-08-07T21:05:35.000Z","date":"2018-08-03","kind":"grant","acquired":true,"shares":41000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vests and becomes exercisable in 12 equal monthly installments beginning on the one-month anniversary of June 7, 2018."}],"balance_after":41000,"derivative":{"exercise_price":1.79,"expiration_date":"2028-08-03","underlying":"Common Stock","underlying_shares":41000},"source":{"system":"sec-edgar","filing":"0001209191-18-045772","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919118045772/doc4.xml","form_type":"4"}},{"id":3850899,"issuer":{"id":4331,"kind":"organization","name":"ChronoScale Holdings Corp","symbol":"CHRN"},"owners":[{"id":108985,"kind":"person","name":"Wang Theodore T","position":1,"cik":"0001694061","reported_name":"Wang Theodore T","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}},{"id":147615,"kind":"organization","name":"Puissance Cross-Border Opportunities II LLC","position":2,"cik":"0001717781","reported_name":"Puissance Cross-Border Opportunities II LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":108984,"kind":"organization","name":"Puissance Capital Fund (GP) LLC","position":3,"cik":"0001695347","reported_name":"Puissance Capital Fund (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":106307,"kind":"organization","name":"Puissance Capital Management LP","position":4,"cik":"0001658437","reported_name":"Puissance Capital Management LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":138534,"kind":"organization","name":"Puissance Capital Management (GP) LLC","position":5,"cik":"0001695339","reported_name":"Puissance Capital Management (GP) LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2018-08-07T21:05:35.000Z","date":"2018-08-03","kind":"grant","acquired":true,"shares":19179,"price":1.79,"value":34330.41,"ownership":{"direct":true},"balance_after":19179,"source":{"system":"sec-edgar","filing":"0001209191-18-045772","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1717781/000120919118045772/doc4.xml","form_type":"4"}}]}